Home > National Drug Code (NDC) > Candesartan Cilexetil and Hydrochlorothiazide

Candesartan Cilexetil and Hydrochlorothiazide - 60505-3758-5 - (Candesartan Cilexetil and Hydrochlorothiazide)

Alphabetical Index


Drug Information of Candesartan Cilexetil and Hydrochlorothiazide

Product NDC: 60505-3758
Proprietary Name: Candesartan Cilexetil and Hydrochlorothiazide
Non Proprietary Name: Candesartan Cilexetil and Hydrochlorothiazide
Active Ingredient(s): 16; 12.5    mg/1; mg/1 & nbsp;   Candesartan Cilexetil and Hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Candesartan Cilexetil and Hydrochlorothiazide

Product NDC: 60505-3758
Labeler Name: Apotex Corp.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA202884
Marketing Category: ANDA
Start Marketing Date: 20121204

Package Information of Candesartan Cilexetil and Hydrochlorothiazide

Package NDC: 60505-3758-5
Package Description: 500 TABLET in 1 BOTTLE (60505-3758-5)

NDC Information of Candesartan Cilexetil and Hydrochlorothiazide

NDC Code 60505-3758-5
Proprietary Name Candesartan Cilexetil and Hydrochlorothiazide
Package Description 500 TABLET in 1 BOTTLE (60505-3758-5)
Product NDC 60505-3758
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Candesartan Cilexetil and Hydrochlorothiazide
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20121204
Marketing Category Name ANDA
Labeler Name Apotex Corp.
Substance Name CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
Strength Number 16; 12.5
Strength Unit mg/1; mg/1
Pharmaceutical Classes Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of Candesartan Cilexetil and Hydrochlorothiazide


General Information